Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea
· Delayed Price · Currency is KRW
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Oct '24 Oct 10, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 19,700 | 15,410 | 35,741 | 51,626 | 78,193 | 145,429 | |
| Market Cap Growth | -45.97% | -56.88% | -30.77% | -33.98% | -46.23% | 77.22% | |
| Enterprise Value | 51,099 | 36,636 | 69,920 | 79,902 | 92,488 | 152,610 | |
| Last Close Price | 2725.00 | 2725.00 | 4950.00 | 7150.00 | 10150.00 | 18400.00 | |
| PS Ratio | 0.58 | 0.30 | 0.57 | 0.84 | 1.62 | 2.89 | |
| PB Ratio | -2.08 | 1.87 | 1.18 | 1.06 | 1.46 | 2.13 | |
| P/TBV Ratio | - | 2.05 | 1.22 | 1.10 | 1.55 | 2.19 | |
| P/OCF Ratio | 50.58 | 37.11 | 26.24 | - | 40.84 | - | |
| EV/Sales Ratio | 1.51 | 0.71 | 1.11 | 1.30 | 1.92 | 3.03 | |
| EV/EBITDA Ratio | - | - | - | 15.18 | - | - | |
| EV/EBIT Ratio | - | - | - | 62.84 | - | - | |
| Debt / Equity Ratio | -2.41 | 2.91 | 1.30 | 0.76 | 0.67 | 0.22 | |
| Debt / EBITDA Ratio | - | - | - | 7.05 | - | - | |
| Debt / FCF Ratio | 127.24 | - | - | - | - | - | |
| Net Debt / Equity Ratio | -2.03 | 2.21 | 1.06 | 0.61 | 0.28 | 0.18 | |
| Net Debt / EBITDA Ratio | -0.74 | -1.16 | -2.98 | 5.62 | -2.31 | -1.72 | |
| Net Debt / FCF Ratio | 107.42 | -34.13 | -35.70 | -3.51 | -2.81 | -1.21 | |
| Asset Turnover | 0.48 | 0.61 | 0.61 | 0.53 | 0.45 | 0.52 | |
| Inventory Turnover | 3.39 | 3.57 | 4.11 | 3.18 | 2.72 | 2.53 | |
| Quick Ratio | 0.32 | 0.42 | 0.70 | 0.70 | 1.11 | 1.28 | |
| Current Ratio | 0.46 | 0.63 | 0.84 | 0.93 | 1.36 | 1.91 | |
| Return on Equity (ROE) | -477.51% | -108.22% | -46.00% | -1.82% | -18.22% | -14.75% | |
| Return on Assets (ROA) | -24.50% | -13.74% | -8.87% | 0.69% | -6.14% | -6.99% | |
| Return on Invested Capital (ROIC) | -184.15% | -41.83% | -20.87% | -1.71% | -14.26% | -13.57% | |
| Return on Capital Employed (ROCE) | -242.90% | -169.90% | -41.50% | 2.40% | -14.00% | -14.60% | |
| Earnings Yield | -154.40% | -135.44% | -50.80% | -1.80% | -14.21% | -6.41% | |
| FCF Yield | 0.91% | -3.47% | -2.52% | -16.33% | -6.72% | -6.90% | |
| Buyback Yield / Dilution | -5.94% | -0.10% | 2.14% | 5.05% | -16.95% | -12.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.